Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets

Alexander P. Bye, Willianne Hoepel, Joanne L. Mitchell, Sophie Jégouic, Silvia Loureiro, Tanya Sage, Gestur Vidarsson, Jan Nouta, Manfred Wuhrer, Steven de Taeye, Marit van Gils, Neline Kriek, Nichola Cooper, Ian Jones, Jeroen den Dunnen, Jonathan M. Gibbins

Blood (2021) 138 (16): 1481–1489.

https://doi.org/10.1182/blood.2021011871

Published: 2021

Includes: Supplemental data

Journal Articles

Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity

Joanne L. Mitchell, Ausra S. Lionikiene, Georgi Georgiev, Anja Klemmer, Chelsea Brain, Paul Y. Kim, Nicola J. Mutch

Blood (2016) 128 (24): 2834–2845.

https://doi.org/10.1182/blood-2015-10-673285

Published: 2016

Includes: Multimedia, Supplemental data

Journal Articles

Path to Diagnosis of Paroxysmal Nocturnal Hemoglobinuria: The Results of an Exploratory Study Conducted By the Aplastic Anemia and Myelodysplastic Syndrome International Foundation and the National Organization for Rare Disorders Utilizing an Internet-Based Survey

Jamile M. Shammo, MD, Rachel L Mitchell, MD, Kylene Ogborn, RN, Ellen Salkeld, Stephanie Chisolm, PhD

Blood (2015) 126 (23): 3264.

https://doi.org/10.1182/blood.V126.23.3264.3264

Published: 2015

Journal Articles

A Striking Reduction of Monoclonal Protein in a Patient with Concurrent Plasma Cell Dyscrasia and CMML-2, after Treatment with Rigosertib (01910.Na)

Jamile M. Shammo, MD, Agne Paner, MD, MV Ramana Reddy, PhD, Rachel L Mitchell, MD, Parameswaran Venugopal, MD

Blood (2015) 126 (23): 5362.

https://doi.org/10.1182/blood.V126.23.5362.5362

Published: 2015

Journal Articles

Functional factor XIII-A is exposed on the stimulated platelet surface

Joanne L. Mitchell, Ausra S. Lionikiene, Steven R. Fraser, Claire S. Whyte, Nuala A. Booth, Nicola J. Mutch

Blood (2014) 124 (26): 3982–3990.

https://doi.org/10.1182/blood-2014-06-583070

Published: 2014

Includes: Multimedia, Supplemental data

Journal Articles

Determination of Optimal Target Antigen and Immune Modulatory Approaches to Improve and Standardize Epstein-Barr Virus-Specific Adoptive T Cell Therapy

Monica L Mitchell, John T. Patton, PhD, Lynn O'Donnell, PhD, Robert A. Baiocchi, MD PhD

Blood (2014) 124 (21): 5817.

https://doi.org/10.1182/blood.V124.21.5817.5817

Published: 2014

Journal Articles

Identifying and Targeting Cytotoxic Tumor-Associated Macrophages in Epstein-Barr Virus-Driven Lymphoproliferative Disease

John T. Patton, PhD, Monica L Mitchell, Li Pan, PhD, A. Douglas Kinghorn, PhD, D.Sc, Michael R. Grever, MD, David M. Lucas, PhD, Robert A. Baiocchi, MD PhD

Blood (2014) 124 (21): 4489.

https://doi.org/10.1182/blood.V124.21.4489.4489

Published: 2014

Journal Articles

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Nita L. Seibel, Peter G. Steinherz, Harland N. Sather, James B. Nachman, Cynthia DeLaat, Lawrence J. Ettinger, David R. Freyer, Leonard A. Mattano, Jr, Caroline A. Hastings, Charles M. Rubin, Kathy Bertolone, Janet L. Franklin, Nyla A. Heerema, Torrey L. Mitchell, Allan F. Pyesmany, Mei K. La, Cheryl Edens, Paul S. Gaynon

Blood (2008) 111 (5): 2548–2555.

https://doi.org/10.1182/blood-2007-02-070342

Published: 2008

Journal Articles

Thalidomide (HAL) Maintenance Following High-Dose Melphalan with Autologous Stem Cell Transplant (ASCT) for Myeloma.

Julie E. Chang, MD, Mark B. Juckett, MD, Brad S. Kahl, MD, Teri L. Mitchell, Ronald E. Gangnon, PhD, Natalie S. Callander, MD, Walter L. Longo, MD

Blood (2006) 108 (11): 5455.

https://doi.org/10.1182/blood.V108.11.5455.5455

Published: 2006

Journal Articles

Outcomes in Children and Adolescents with a Markedly Elevated White Blood Cell Count (>200,000) at Diagnosis of High Risk Acute Lymphoblastic Leukemia (ALL): A Report from the Children’s Oncology Group.

Caroline Hastings, MD, Harland N. Sather, PhD, Nita L. Seibel, MD, James Nachman, MD, Peter G. Steinherz, MD, Kathy Bertolone, FNP, Cynthia DeLaat, MD, Lawrence J. Ettinger, MD, Janet Franklin, MD, David Robert Freyer, DO, Leonard A. Mattano, MD, Torrey L. Mitchell, MD, Charles M. Rubin, MD, Allan F. Pyesmany, MD, Nyla A. Heerema, PhD, Cheryl Edens, Paul S. Gaynon, MD

Blood (2006) 108 (11): 1870.

https://doi.org/10.1182/blood.V108.11.1870.1870

Published: 2006

Journal Articles

Inhibition of CKS1B Expression Affects Myeloma Cell Growth In Vivo.

Bangzheng Chen, Ling Liu, Kristin L. Mitchell, Xiasong Wu, Simona Colla, Fenghuang Zhan, John D. Shaughnessy, Jr.

Blood (2006) 108 (11): 370.

https://doi.org/10.1182/blood.V108.11.370.370

Published: 2006

Journal Articles

T Cell Recognition of HCMV: Pan-Genome Analysis of Immunogenic Open-Reading Frames.

Louis J. Picker, MD, Andrew W. Sylwester, PhD, Bridget L. Mitchell, BA, Cara Taormina, BS, Christian Pelte, MD, John Edgar, BA, Florian Kern, MD, Paul Sleath, PhD, Kenneth Grabstein, PhD, Jay Nelson, PhD, Nancy Hosken, PhD

Blood (2004) 104 (11): 606.

https://doi.org/10.1182/blood.V104.11.606.606

Published: 2004

Journal Articles

Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients

W. Streif, M. Andrew, V. Marzinotto, P. Massicotte, A.K.C. Chan, J.A. Julian, L. Mitchell

Blood (1999) 94 (9): 3007–3014.

https://doi.org/10.1182/blood.V94.9.3007

Published: 1999

Journal Articles

Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency

L Mitchell, H Hoogendoorn, AR Giles, P Vegh, M Andrew

Blood (1994) 83 (2): 386–391.

https://doi.org/10.1182/blood.V83.2.386.386

Published: 1994

Journal Articles

Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis

MA Delorme, N Saeed, A Sevcik, L Mitchell, L Berry, M Johnston, M Andrew

Blood (1993) 82 (11): 3380–3385.

https://doi.org/10.1182/blood.V82.11.3380.3380

Published: 1993

Journal Articles

Maturation of the hemostatic system during childhood

M Andrew, P Vegh, M Johnston, J Bowker, F Ofosu, L Mitchell

Blood (1992) 80 (8): 1998–2005.

https://doi.org/10.1182/blood.V80.8.1998.1998

Published: 1992

Journal Articles

Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children

L Mitchell, F Piovella, F Ofosu, M Andrew

Blood (1991) 78 (9): 2299–2304.

https://doi.org/10.1182/blood.V78.9.2299.2299

Published: 1991

Journal Articles

Development of the human coagulation system in the healthy premature infant

M Andrew, B Paes, R Milner, M Johnston, L Mitchell, DM Tollefsen, V Castle, P Powers

Blood (1988) 72 (5): 1651–1657.

https://doi.org/10.1182/blood.V72.5.1651.1651

Published: 1988

Journal Articles

Development of the human coagulation system in the full-term infant

M Andrew, B Paes, R Milner, M Johnston, L Mitchell, DM Tollefsen, P Powers

Blood (1987) 70 (1): 165–172.

https://doi.org/10.1182/blood.V70.1.165.165

Published: 1987

NARROW

Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets

Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity

Path to Diagnosis of Paroxysmal Nocturnal Hemoglobinuria: The Results of an Exploratory Study Conducted By the Aplastic Anemia and Myelodysplastic Syndrome International Foundation and the National Organization for Rare Disorders Utilizing an Internet-Based Survey

A Striking Reduction of Monoclonal Protein in a Patient with Concurrent Plasma Cell Dyscrasia and CMML-2, after Treatment with Rigosertib (01910.Na)

Functional factor XIII-A is exposed on the stimulated platelet surface

Determination of Optimal Target Antigen and Immune Modulatory Approaches to Improve and Standardize Epstein-Barr Virus-Specific Adoptive T Cell Therapy

Identifying and Targeting Cytotoxic Tumor-Associated Macrophages in Epstein-Barr Virus-Driven Lymphoproliferative Disease

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Thalidomide (HAL) Maintenance Following High-Dose Melphalan with Autologous Stem Cell Transplant (ASCT) for Myeloma.

Outcomes in Children and Adolescents with a Markedly Elevated White Blood Cell Count (>200,000) at Diagnosis of High Risk Acute Lymphoblastic Leukemia (ALL): A Report from the Children’s Oncology Group.

Inhibition of CKS1B Expression Affects Myeloma Cell Growth In Vivo.

T Cell Recognition of HCMV: Pan-Genome Analysis of Immunogenic Open-Reading Frames.

Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients

Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency

Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis

Maturation of the hemostatic system during childhood

Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children

Development of the human coagulation system in the healthy premature infant

Development of the human coagulation system in the full-term infant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only